Combination Therapy Improved Chemoresistance in Ovarian Cancer

News   Nov 04, 2016

 
Combination Therapy Improved Chemoresistance in Ovarian Cancer
 
 
 

RELATED ARTICLES

Attacking 'Undruggable' Cancers from the Outside In

News

Many of the most common cancer-causing genes are so central to cellular function throughout the body that they are essentially 'undruggable'. Now, researchers have found a way to attack one of the most common drivers of lung, colorectal, and pancreatic cancer by targeting the proteins it produces on the outside of the cell.

READ MORE

Latent HIV Reservoirs Inherently Resistant to Elimination by CD8+ T-cells

News

The latest “kick-and-kill” research to eliminate the HIV virus uncovered a potential obstacle in finding a cure. A recent study found that latent HIV reservoirs show resistance to CD8+ T-cells, a type of white blood cell whose primary function is to kill infected cells.

READ MORE

LifeArc and Milner Therapeutics Institute Announce a New Partnership in AI for Target Discovery

News

LifeArc®, the UK-based medical research charity, and the Milner Therapeutics Institute at the University of Cambridge, today announced a new partnership to identify and validate new drug targets in immuno-oncology and respiratory diseases.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE